Advanced Filters
noise

kidney-failure Clinical Trials

A listing of kidney-failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 614 clinical trials
C Chi-Ting Su, MD, MPH, PhD

Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction

The project is planed to explore the impact of LTBP4 and other matrix protein and potentially related biomarkers on renal outcomes, cardiac outcomes and all-cause mortality in patients with suspected acute coronary syndrome (ACS).

20 - 80 years of age All Phase N/A

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive A Kidney Transplant

The primary objective of the study is to assess adverse events (AEs) and serious adverse events (SAEs) in kidney transplant recipients previously treated with REGN5459 or REGN5458 in the R5459-RT-1944 study. The secondary objectives of the study are to evaluate each of the following in kidney transplant recipients previously treated …

18 - 70 years of age All Phase N/A
Y Yu Shi, MD

Multifrequency MRE in Evaluation of Chronic Kidney Diseases

Chronic Kidney Disease (CKD) is a major public health issue, leading to high mortality and the necessity for renal replacement therapy. Kidney fibrosis, resulting from chronic damage to kidney tissue, significantly determines CKD outcomes. Kidney biopsy, the gold standard for assessing fibrosis, is invasive and limited in its ability to …

18 - 65 years of age All Phase N/A
M Matthias Kretzler, MD

University of Michigan "Nephrology Research BioBank"

The purpose of the study is to create a Nephrology Tissue Biobank enabling the study of kidney disease from the perspectives of epidemiology, genetics and molecular biology.

years of age All Phase N/A
V Valérie PRUDHOMME, Dietician

Assessment of Protein Intake Using 2 Types of Nutritional Collection in Chronic Kidney Disease.

In France, 10% of the population suffers from chronic kidney disease (CKD). CKD is classified into five stages, described from the least severe (stage 1) to the most severe (stage 5). Every year, in the PACA region, around 1,000 new patients present with end-stage CKD (5D), necessitating the introduction of …

18 years of age All Phase N/A

Evolution of Bone Histomorphometry and Vascular Calcification Before and After Renal Transplantation

A study of the natural history of bone and mineral disease (BMD) in patients with end-stage renal disease before and after kidney transplantation

18 years of age All Phase N/A
N Naciye Vardar-Yağlı, Prof. Dr.

Functional Capacity in Children with Chronic Kidney Disease

The aim of our study is to assess the functional capacity of children with chronic kidney disease using various tests.

6 - 18 years of age All Phase N/A
P Pei Nie

Multimodal Imaging Assessment of Chronic Kidney Disease Patients at Different Stages From a Cardio-Renal Interaction Perspective

This study is a prospective cohort investigation in which consecutive eligible patients undergo 18F-FAPI PET/MR imaging. Chronic kidney disease (CKD) participants are stratified into two groups:Group I :CKD stages 1-3(eGFR ≥ 30 mL/min/1.73 m²),Group II :CKD stages 4-5(eGFR < 30 mL/min/1.73 m²). Using 18F-FAPI PET/MR, we will evaluate global cardiac …

18 - 80 years of age All Phase N/A

Intestinal Transport of Microbial Metabolites in Chronic Kidney Disease

Chronic kidney disease is associated with the accumulation of various metabolites, i.e., uremic retention solutes. Evidence is mounting that the colonic microbiome contributes substantially to these uremic retention solutes. Indoxyl sulfate and p-cresyl sulfate are among the most extensively studied gut microbial metabolites, and are associated with cardiovascular disease, chronic …

18 - 85 years of age All Phase N/A
O Oliver Gross, MD

European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

The hereditary type IV collagen disease Alport syndrome inevitably leads to end-stage renal disease. Currently there are no therapies known to improve outcome. Our non-interventional, observational study investigates, if medications such as ACE-inhibitors can (1) delay time to dialysis and (2) improve life-expectancy within three generations of Alport-families in Europe.

years of age All Phase N/A

Simplify language using AI